Vargas, C. L., Espinoza, M. A., Giglio, A., & Soza, A. (2015). Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile. PLoS One.
Stile di citazione ChicagoVargas, Constanza L., Manuel A. Espinoza, Andrés Giglio, e Alejandro Soza. "Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis C Genotype 1b Naïve Patients in Chile." PLoS One 2015.
Citazione MLAVargas, Constanza L., Manuel A. Espinoza, Andrés Giglio, e Alejandro Soza. "Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis C Genotype 1b Naïve Patients in Chile." PLoS One 2015.